MyFinsight
Home
Blog
About
Contact
xene: the balance sheet
Download
Download image
Prepaid expenses and
other current assets
$17,057K
Other receivables
$812K
Marketable securities
(note 5)
$357,754K
Cash and cash
equivalents
$104,514K
Prepaid expenses,
long-term
$7,114K
Deferred tax assets
$11,750K
Property, plant and
equipment, net
$8,887K
Operating lease
right-of-use asset, net (note...
$6,960K
Marketable securities,
long-term (note 5)
$92,988K
Total current assets
$480,137K
Total assets
$607,836K
Total liabilities and
shareholders equity
$607,836K
Total shareholders'
equity
$559,511K
Total liabilities
$48,325K
Accumulated deficit
-$1,140,119K
Accumulated other
comprehensive income (loss)
$477K
Additional paid-in capital
$223,782K
Common shares, without
par value unlimited...
$1,475,371K
Other liabilities,
long-term
$3,158K
Operating lease
liability, long-term (note...
$6,832K
Total current
liabilities
$38,335K
Operating lease liability
(note 6)
$1,495K
Accounts payable and
accrued liabilities...
$36,840K
Back
Back
Balance Sheet
source: myfinsight.com
logo_icon_teal_2280px-svg
Xenon Pharmaceuticals Inc. (XENE)
logo_icon_teal_2280px-svg
Xenon Pharmaceuticals Inc. (XENE)